Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Clinical trial NCT06780670 · RECRUITING
Trial details
- NCT number
- NCT06780670
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-27
- Primary completion
- 2028-06-27
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.